Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT05366868 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05366868
- Sponsor
- National Center for Global Health and Medicine, Japan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-26
- Primary completion
- 2026-08-31
- Enrollment
- 567
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.